Literature DB >> 3945904

Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome.

J Jääskeläinen, M Haltia, A Servo.   

Abstract

Out of 936 primary intracranial meningiomas, 94.3% were histologically benign (grade I), 4.7% atypical (grade II), and 1.0% anaplastic (grade III); one recurrence was sarcomatous (grade IV). Meningiomas with histologic anaplasia (grades II-IV) occurred in 12% of the men, but only 4% of the women. Only 26% of atypical or anaplastic meningiomas appeared completely innocent on a computed tomography scan. Angiograms, usually showing a meningeal feeding artery, suggested meningioma when computed tomography scans did not. At 5 years after complete removal, the recurrence rate was only 3% (21% at 25 years) for benign meningiomas, but 38% for atypical ones, and 78% for anaplastic ones. The median times to recurrence were 7.5, 2.4, and 3.5 years, respectively. In spite of postoperative radiotherapy, four of five anaplastic meningiomas recurred.

Entities:  

Mesh:

Year:  1986        PMID: 3945904     DOI: 10.1016/0090-3019(86)90233-8

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  95 in total

1.  Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma.

Authors:  S Ozaki; T Nishizaki; H Ito; K Sasaki
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 2.  Tumors of the meninges: proposed modifications of the World Health Organization classification.

Authors:  B W Scheithauer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases.

Authors:  S Epari; M C Sharma; C Sarkar; A Garg; A Gupta; V S Mehta
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

Review 4.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

Review 5.  Fractionated radiotherapy for intracranial meningiomas.

Authors:  Vinai Gondi; Wolfgang A Tome; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

6.  Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma.

Authors:  A Gabriella Wernicke; Adam P Dicker; Michal Whiton; Jana Ivanidze; Terry Hyslop; Elizabeth H Hammond; Arie Perry; David W Andrews; Lawrence Kenyon
Journal:  Radiat Oncol       Date:  2010-05-30       Impact factor: 3.481

7.  Sellar meningiomas: an endocrinologic perspective.

Authors:  Matheni Sathananthan; Airani Sathananthan; Bernd W Scheithauer; Caterina Giannini; Fredric B Meyer; John L D Atkinson; Dana Erickson
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

8.  Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act.

Authors:  Therese A Dolecek; Emily Van Meter Dressler; Jigisha P Thakkar; Meng Liu; Abeer Al-Qaisi; John L Villano
Journal:  Cancer       Date:  2015-04-14       Impact factor: 6.860

9.  The influence of age on the histological grading of meningiomas.

Authors:  Jae-Sung Park; Burak Sade; Soichi Oya; Chong Gue Kim; Joung H Lee
Journal:  Neurosurg Rev       Date:  2014-04-29       Impact factor: 3.042

10.  Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.

Authors:  Beatrice Detti; Silvia Scoccianti; Vanessa Di Cataldo; Eleonora Monteleone; Samantha Cipressi; Lorenzo Bordi; Gianni Pellicanò; Davide Gadda; Calogero Saieva; Daniela Greto; Guido Pecchioli; Annamaria Buccoliero; Marco Ceroti; Franco Ammannati; Giampaolo Biti
Journal:  J Neurooncol       Date:  2013-09-18       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.